Aster Hospital Mankhool and Medcare Hospital Al Safa recognized for medical excellence at the Dubai Quality Group Award
Dubai, UAE – Aster Hospital Mankhool and Medcare Hospital Al Safa, part of Aster DM Healthcare—the leading integrated healthcare provider in the GCC—have been recognized for their commitment to quality and innovation in healthcare at the prestigious Dubai Quality Group Award held recently. The two hospitals achieved top honors, with Aster Hospital Mankhool securing the Gold category and Medcare Hospital Al Safa earning the Silver category at the 1st Cycle of the Medical Excellence MENA Award, organized by the Medical Excellence Subgroup of Dubai Quality Group.
Under the patronage of His Highness Sheikh Ahmed bin Saeed Al Maktoum, the Medical Excellence Subgroup of Dubai Quality Group launched this esteemed award to promote a culture of excellence, innovation, and safety in the healthcare sector across the UAE, GCC, and MENA region. The award recognizes institutions that set benchmarks in quality healthcare delivery, aligning with globally accepted best practices and fostering patient-centric care.
The award ceremony, held at the Habtoor Ballroom, Al Habtoor Palace, was attended by His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of Dubai Civil Aviation Authority, Chairman of Dubai Airports and Chairman and Chief Executive of Emirates Airline and Group, along with Dr. Hazza Khalfan Alnuaimi, Chairman of Dubai Quality Group. The event, hosted by Mrs. Sameera Mohammed, General Manager of Dubai Quality Group, brought together over 600 dignitaries, state and regional leaders, executive presidents, and representatives from local and international media, celebrating outstanding contributions to healthcare excellence.
Speaking on this remarkable achievement, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said, "This accolade reinforces our mission to set new benchmarks in clinical excellence, safety, and patient experience across our hospitals. At Aster, there has been a paradigm shift in the way we measure clinical excellence – moving from a provider perspective to the receiver's perspective. In simple terms, we capture our clinical outcomes as determined by the patients' reporting outcomes of care (PROM – Patient Reported Outcome Measures) and patients' reporting their experience of care (PREM – Patient Reported Experience Measures). This ensures great value add to the patients, which was well appreciated during the assessment."
Dr. Arshanapalai added, "Aster Hospital Mankhool's recognition in the Gold category and Medcare Al Safa's Silver category win are a testament to the dedication of our teams in delivering high-quality, patient-centric care. These achievements highlight our unwavering commitment to adopting best practices, ensuring optimal healthcare outcomes, and continuously innovating to meet the evolving needs of our patients."
Echoing this sentiment, Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics, UAE, Oman & Bahrain, emphasized the significance of this recognition, stating, 'Receiving the Dubai Quality Group Award is a testament to Aster's unwavering commitment to delivering world-class healthcare services. Aster Hospital Mankhool's recognition in the Gold category reflects our dedication to clinical excellence, patient safety, and continuous innovation. Our highly skilled professionals and the clinical expertise of our doctors have won us this recognition, topped with rigorous protocols ensuring the best possible clinical outcomes. Above all, compassion and empathy are our core values, and today we stand proud of this accolade. This honor fuels our passion to elevate healthcare standards and enhance patient experiences across the region.'
Adding to the celebration, Dr. Shanila Laiju, Group CEO of Medcare Hospitals and Medical Centres, stated, "Medcare Hospital Al Safa's Silver category win highlights our commitment to medical excellence and a patient-first approach. We will continue to implement advanced medical practices and innovations that enhance patient care and strengthen the UAE's position as a global healthcare hub."
The Medical Excellence MENA Award under Dubai Quality Group was established to promote the UAE as a health tourism hub, foster a competitive healthcare environment, ensure safe and high-quality medical care, and integrate ESG (Environmental, Social, and Governance) principles into healthcare institutions. The award aligns with the UAE's vision of elevating healthcare standards and promoting sustainable excellence in the industry.
In addition to these accolades, Aster DM Healthcare has recently been honored with the Dubai Quality Appreciation Award, reinforcing its position as a leading healthcare provider committed to excellence. Aster Hospital Mankhool has also achieved accreditation from the Emirates International Accreditation Centre, further validating its commitment to maintaining the highest standards in patient safety and healthcare delivery. Medcare Hospital Al Safa continues to raise the bar with its Joint Commission International (JCI) reaccreditation, emphasizing its adherence to global best practices in healthcare.
The recognition of Aster Hospital Mankhool and Medcare Hospital Al Safa at the Dubai Quality Group Award further solidifies their position as leaders in delivering exceptional healthcare services. Their dedication to medical excellence, patient safety, and quality care continues to set new benchmarks for the region's healthcare landscape, reinforcing their commitment to innovation and world-class healthcare delivery.
About Aster DM Healthcare FZC in GCC
Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across all six countries in the GCC. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'. The organisation's robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster.
For more information:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
28-05-2025
- Al Etihad
Under directives of Mansour bin Zayed, Theyab bin Mohamed approves contribution of Dh100m from Erth Zayed Philanthropies to Life Endowment campaign
28 May 2025 19:44 ABU DHABI (WAM) Under the directives of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister, and Chairman of the Presidential Court, H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs and Chairman of the Board of Trustees of Erth Zayed Philanthropies, has approved the allocation of Dh100 million from Erth Zayed Philanthropies to the Life Endowment campaign to support individuals in Abu Dhabi with chronic commitment will prioritise support for People of Determination living with chronic illnesses, funding access to treatment, medicines, and other critical health services.H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan said, 'The launch of the Life Endowment campaign reflects the UAE's enduring values of solidarity, social cohesion, and shared responsibility. Rooted in the humanitarian legacy of our Founding Father, the late Sheikh Zayed bin Sultan Al Nahyan, and guided by the vision of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, this initiative reaffirms the UAE's commitment to respond to needs, build resilience, and empower long-term solutions. Through this endowment, we can offer critical support, upholding the principle that access to care should never be determined by circumstance.''The contribution by Erth Zayed Philanthropies is testament to our leadership's commitment to ensuring inclusive and sustainable healthcare access to everyone, giving them the opportunity to lead healthy, promising lives.'The Life Endowment campaign aims to secure sustainable funding for individuals with chronic illnesses to ensure ongoing access to care. The initiative will fund treatment, essential medicines, and psychological support, while also helping to advance healthcare services and will be disbursed directly to hospitals and healthcare providers to support the treatment of eligible patients, subject to the review of each at maximising social returns through endowment-based financing, the campaign positions healthcare not just as a public service, but as a national priority. It promotes the role of endowments as a model for impactful social investment, reinforcing the UAE's leadership in sustainable philanthropy and inclusive development.
Al Etihad
14-05-2025
- Al Etihad
UAE urgently evacuates 188 patients, family members from Gaza
15 May 2025 00:44 ABU DHABI (WAM)Following the directives of UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan to provide treatment and healthcare to 1,000 wounded Palestinian children and 1,000 cancer patients from the Gaza Strip in UAE hospitals, the UAE - in cooperation with the World Health Organisation (WHO) - has conducted its latest evacuation flight from Ramon airport in Israel, via Karam Abu Salam crossing, carrying 101 injured people, and accompanied by 87 family far, 2,630 patients and family members have arrived in the UAE, which reflects the country's commitment to providing the necessary medical treatment for Palestinians in UAE Al Shamsi, Assistant Minister of Foreign Affairs for Development and International Organisations and Vice Chairman of the UAE Aid Agency, said, "The initiative launched by His Highness Sheikh Mohamed Bin Zayed Al Nahyan, UAE President, demonstrates the UAE's long-standing support for the brotherly Palestinian people, and the country's solidarity with the people of Gaza during the ongoing crisis. The UAE humanitarian initiatives contribute to alleviating the disastrous impacts endured by residents of the Strip, particularly children, women, and the elderly."Al Shamsi added, "During this critical time, the UAE will spare no effort to extend help to the Palestinians and launch initiatives for their aid whether by land, sea, or air. We will continue to closely work –through our leading and pioneering role - with the United Nations and our international partners to intensify the necessary efforts to alleviate the humanitarian catastrophe in Gaza, and ensure the urgent, safe, unhindered, and sustainable delivery of aid at a wide scale and through all possible means."He further highlighted, "The UAE is among the leading countries in providing support to the people in Gaza. Since the onset of the crisis in October 2023, the country has provided over 40% of the total amount of aid delivered."Al Shamsi affirmed that the UAE's continuous efforts to conduct medical evacuation flights reflect the country's commitment to providing advanced medical healthcare to injured Palestinians, and to contribute to humanitarian efforts during these critical conditions. Al Shamsi affirmed that the UAE will implement all measures to support the people of Gaza during these difficult circumstances, and will continue its humanitarian and relief endeavours to evacuate injured people and patients, which reflect the country's steadfast commitment to saving lives. Al Shamsi added, "Since the outbreak of the crisis, the UAE has undertaken robust efforts to provide advanced healthcare to sick and severely injured Palestinians in the UAE field hospital in the southern Gaza Strip and the hospital ship anchored in Al-Arish Port. Since the beginning of the crisis, the UAE has provided a wide-scale relief response for the brotherly Palestinians to support them during the ongoing critical circumstances. The country has provided over 65,000 tonnes of relief, food, and medical supplies."
Al Etihad
14-05-2025
- Al Etihad
Under the patronage of Sheikha bint Saif, Burjeel Holdings launches Thalassemia and Sickle Cell Centre
14 May 2025 10:11 ABU DHABI (ALETIHAD)Under the patronage of Sheikha Shaikha bint Saif bin Mohamed Al Nahyan, wife of His Highness Sheikh Sultan bin Khalifa Al Nahyan, Advisor to His Highness the President, and Chairperson of the Emirates Thalassemia Society, Burjeel Holdings has launched a Thalassemia and Sickle Cell Centre at its flagship quaternary care hospital, Burjeel Medical City (BMC) in Abu Dhabi, in a step towards redefining the standard of care for individuals with inherited blood centre was inaugurated in a grand ceremony also attended by Sheikh Khalifa bin Sultan bin Khalifa Al Nahyan, Dr Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Omran Al Khoori, Board Member, and a number of Burjeel leaders. The opening was also attended by members of the Board of Directors of the Emirates Thalassemia Society and a number of leaders from the Department of Health, Abu Shamma bint Sultan bin Khalifa Al Nahyan said in the opening speech she delivered on this occasion: "In my mother's unwavering commitment to thalassemia patients, I have witnessed how compassion, when paired with vision and persistence, can transform countless lives across generations and beyond borders. The newly inaugurated Thalassemia and Sickle Cell Centre by Burjeel Holdings' state-of-the-art facility will provide compassionate and comprehensive care to patients and their families."The centre supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care, supported by a multidisciplinary team of world-renowned centre offers fully integrated outpatient services and a dedicated transfusion unit operating seven days a week. The centre is distinguished by several key differentiators, including extended transfusion services across the UAE via Burjeel's hospital network, internationally validated MRI quantification of iron overload in the heart and liver, and in-house molecular genotyping capabilities. Patients are cared for by experts with decades of experience in managing both pediatric and adult cases of thalassemia and sickle cell disease. With the MENA region reporting considerably high prevalence rates of thalassemia and sickle cell disease, the centre aims to bridge critical gaps in long-term care. The centre's strategic location within a quaternary care facility ensures direct access to advanced medical and surgical subspecialties, enabling seamless referrals and comprehensive management of Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, and Director of the Thalassemia & Sickle Cell Centre, said: 'Our goal is to establish the Thalassemia and Sickle Cell Centre as a regional hub for cutting-edge care and research in rare blood disorders. What makes this centre unique is the combination of global clinical expertise, access to the latest therapies, and the ability to deliver care in line with international guidelines authored by the very people leading the services here. We are not only focused on treatment, but also on improving patients' quality of life and future outcomes through holistic, personalised care.'With an international advisory board of global key opinion leaders, the centre adheres to leading global standards, including those of the Thalassaemia International Federation, with necessary local adaptations to meet the specific needs of patients in the UAE and MENA region. Its continuum of care begins at diagnosis and spans childhood to adulthood, with tailored transition programmes and advanced treatments for conditions including transfusion-dependent β-thalassemia (TDT), non-transfusion-dependent β-thalassemia (NTDT), and sickle cell disease. The centre will also work closely with the Centre for Research on Rare Blood Disorders (CR-RBD) at BMC, also headed by Prof Khaled Musallam, to identify and enrol eligible patients in global clinical trials, ensuring access to the latest innovations in treatment, including disease-modifying and curative therapies. Source: Aletihad - Abu Dhabi
